People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Paulex Bio Inc. | — | Pharmaceuticals | Series B | $18.5M | $74.8M | 2025 |
| Lapix Therapeutics Inc. | — | Biotechnology | Series A | $14.9M | $6.9M | 2024 |
Francisco Leon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Francisco Leon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Norris | 1 | 5 |
| Mohammad Hayat | 1 | 1 |
| Sanjuan Miguel | 1 | 1 |
| Edgardo Rayo | 1 | 1 |
| Anthony Gibney | 1 | 1 |
| Henry McKinnell | 1 | 1 |
| Anas Fathallah | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.